Company Performance Update – Oric (ORIC)
Trading Session Summary
- Oric (ORIC) closed the 24‑hour period ending 05:59 AM Central European Time on Thursday, 22 October 2026, up 8.33 %.
- The stock is currently priced at USD 13.85 on major exchanges.
Market Metrics
- Shares outstanding: 103.8 million.
- Market capitalization: USD 1.3 billion.
- Trading volume in the last 24 hours: approximately USD 27.8 million.
- Since the end of the previous month, Oric has gained 8.76 %.
- 200‑day simple moving average: USD 11.08.
- 52‑week high: USD 14.68 (recorded 19 August 2026).
- 52‑week low: USD 7.23 (recorded 2 April 2026).
Peer Comparison – 24‑Hour Performance
| Ticker | 24‑Hour Change | Current Price (USD) | Market Capitalization (USD) | Additional Ratio |
|---|---|---|---|---|
| Nuvation Bio (NUVB) | +6.47 % | 4.85 | 1.6 billion | – |
| Cts (CTS) | –0.22 % | 56.23 | 1.6 billion | P/E: 23.24 |
| Braveheart Bio (BRVE) | +5.52 % | 21.04 | 1.6 billion | – |
| Amn Healthcare Services (AMN) | +2.77 % | 43.01 | 1.6 billion | P/E: 15.48 |
| Structure Therapeutics (GPCR) | +3.95 % | 22.01 | 1.6 billion | – |
Company Overview ORIC Pharmaceuticals, Inc. is headquartered in South San Francisco, United States, and operates within the healthcare sector. The company focuses on the discovery and development of novel treatments for cancer diseases. Oric’s customer base is primarily located in California. Further information about the company’s products and research can be accessed on its website, www.oricpharma.com . The company’s shares are listed on the Nasdaq stock exchange.
